Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LOXO | CERE | JAZZ | ||
| Company | Loxo Oncology CS | Cerevel Therapeutics Hldg Inc | Jazz Pharma Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 234.80 | 42.57 | 110.96 | ||
| High | 234.80 | 42.79 | 112.15 | ||
| Low | 234.80 | 42.56 | 110.76 | ||
| Last | 234.80 | 42.70 | 111.42 | ||
| Change | +0.14 | -0.05 | +0.20 | ||
| % Change | +0.06% | -0.12% | +0.18% | ||
| Volume | 800 | 198,632 | 93,193 | ||
| 20-Day Average Volume | 642,620 | 1,070,390 | 524,241 | ||
| Previous Close | 234.66 | 42.75 | 111.22 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 234.28 | 42.10 | 111.42 | ||
| 20-Day Raw Stochastic | 92.26% | 91.57% | 43.36% | ||
| 20-Day Relative Strength | 75.87% | 61.07% | 44.07% | ||
| Weighted Alpha | +47.60 | +16.36 | -20.77 | ||
| Today's Opinion | 100% Buy | 88% Buy | 88% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.16% since 02/08/19 | +1.70% since 04/23/24 | +1.71% since 04/23/24 | ||
| Low | 234.43 on 02/11/19 | 41.80 on 04/25/24 | 106.73 on 04/26/24 | ||
| High | 234.93 on 02/13/19 | 42.85 on 04/29/24 | 112.17 on 04/29/24 | ||
| 1-Month | |||||
| %Chg | +0.48% since 01/15/19 | +1.03% since 03/28/24 | -7.37% since 03/28/24 | ||
| Low | 233.14 on 01/16/19 | 41.19 on 04/16/24 | 106.61 on 04/17/24 | ||
| High | 234.93 on 02/13/19 | 42.85 on 04/29/24 | 120.81 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | +54.95% since 11/15/18 | +1.46% since 01/30/24 | -11.16% since 01/30/24 | ||
| Low | 125.00 on 12/24/18 | 40.66 on 02/22/24 | 106.61 on 04/17/24 | ||
| High | 234.93 on 02/13/19 | 43.59 on 02/15/24 | 134.17 on 02/26/24 | ||
| 6-Month | |||||
| %Chg | +49.33% since 08/15/18 | +83.76% since 10/30/23 | -10.73% since 10/30/23 | ||
| Low | 125.00 on 12/24/18 | 22.27 on 10/31/23 | 106.61 on 04/17/24 | ||
| High | 234.93 on 02/13/19 | 43.59 on 02/15/24 | 134.48 on 11/07/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,182,943 | 7,762,375 | 7,006,860 | ||
| Shares Outstanding, K | 30,615 | 181,576 | 63,000 | ||
| Annual Sales | 21,300,000 | 0 | 3,834,200,000 | ||
| Annual Net Income | -148,880,000 | -432,840,000 | 414,830,000 | ||
| Last Quarter Sales | 42,470,000 | 0 | 1,011,940,000 | ||
| Last Quarter Net Income | -27,060,000 | -132,660,000 | 94,150,000 | ||
| 60-Month Beta | 2.51 | 1.48 | 0.59 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.89 on 11/08/18 | -0.61 on 11/01/23 | 5.02 on 02/28/24 | ||
| Latest Earnings Date | 03/07/19 | 05/01/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.99 | ||